"VSports" Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in VSports app下载. gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site. .

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. V体育官网.

. 2013 Oct;1(5):368-74.
doi: 10.1177/2050640613501818.

Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn's disease after ileocolonic resection: A prospective pilot study (V体育安卓版)

Takayuki Yamamoto  1 , Manabu Shiraki  1 , Takuya Bamba  1 , Satoru Umegae  1 , Koichi Matsumoto  1
Affiliations

Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn's disease after ileocolonic resection: A prospective pilot study

Takayuki Yamamoto et al. United European Gastroenterol J. 2013 Oct.

Abstract

Background: Several studies have reported that faecal calprotectin and lactoferrin showed a close correlation with endoscopic inflammation in patients with inflammatory bowel disease VSports手机版. However, the clinical significance of faecal calprotectin or lactoferrin in postoperative Crohn's disease (CD) is not fully evaluated. This prospective study was to investigate the relationship between endoscopic activity, and faecal calprotectin and lactoferrin, and assess the predictive value of these markers for future recurrence. .

Methods: Twenty patients who remained in remission during 6-12 months after ileocolonic resection for CD were included V体育安卓版. All patients underwent ileocolonoscopy for assessing endoscopic activity (Rutgeerts score) in the neo-terminal ileum. A stool sample was collected for measurement of calprotectin and lactoferrin. All patients were then followed up for 12 months, and clinical recurrence was defined as a CDAI >150 with an increase of ≥70 points. .

Results: The mean time between surgery and the endoscopic examination at entry was 7. 2 months. The endoscopic scores were i0 or i1 in 10 patients, i2 in six patients, i3 in three patients, and i4 in one patient. Both calprotectin and lactoferrin positively correlated with the endoscopic scores (p = 0. 0001 and p = 0. 038, respectively) V体育ios版. Six patients developed clinical recurrence during the 12-month follow-up. Both calprotectin and lactoferrin levels were significantly higher in patients with clinical recurrence than those in remission (p = 0. 0007 and p = 0. 025, respectively). A cutoff value of 170 µg/g for calprotectin had a sensitivity of 83% and a specificity of 93% to predict a risk of clinical recurrence, while a cutoff value of 140 µg/g for lactoferrin had a sensitivity of 67% and a specificity of 71%. .

Conclusions: Both calprotectin and lactoferrin levels correlate well with endoscopic activity after ileocolonic resection for CD. Calprotectin and lactoferrin could be clinically relevant biomarkers for predicting postoperative recurrence VSports最新版本. Further well-designed large trials should strengthen the findings of the present investigation. .

Keywords: Calprotectin; Crohn’s disease; faecal marker; lactoferrin. postoperative recurrence V体育平台登录. .

PubMed Disclaimer

"V体育ios版" Figures

Figure 1.
Figure 1.
Both calprotectin (a) and lactoferrin (b) levels significantly positively correlated with the endoscopic scores in the neo-terminal ileum. The mean ± SE values are presented.
Figure 2.
Figure 2.
The bar represents mean value with SE. Both calprotectin (a) and lactoferrin (b) levels were significantly higher in patients with clinical recurrence than in patients in remission.
Figure 3.
Figure 3.
The cumulative recurrence rate was significantly higher in patients with high calprotectin levels (≥170 µg/g) than in those with low calprotectin levels (<170 µg/g) (a). The cumulative recurrence rate was higher in patients with high lactoferrin levels (≥140 µg/g) than in those with low lactoferrin levels (<140 µg/g), but the difference did not reach statistical significance (b).
See this image and copyright information in PMC

References

    1. Van Assche G, Dignass A, Panes J, et al. . The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: Definitions and diagnosis. J Crohns Colitis 2010; 4: 7–27 - PubMed
    1. Poullis A, Foster R, Mendall MA, et al. . Emerging role of calprotectin in gastroenterology. J Gastroenterol Hepatol 2003; 18: 756–762 - VSports手机版 - PubMed
    1. Voganatsi A, Panyutich A, Miyasaki KT, et al. . Mechanism of extracellular release of human neutrophil calprotectin complex. J Leukoc Biol 2001; 70: 130–134 - PubMed
    1. Roseth AG, Fagerhol MK, Aadland E, et al. . Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992; 27: 793–798 - PubMed
    1. Johne B, Fagerhol MK, Lyberg T, et al. . Functional and clinical aspects of the myelomonocytic protein calprotectin. J Clin Pathol Mol Pathol 1997; 50: 113–123 - "VSports手机版" PMC - PubMed